ADE LLC’s Pfizer PFE Stock Holding History

ADE LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$310K	Hold	11,028	–	–	0.15%	72
2025 Q4	$275K	Hold	11,028	–	–	0.13%	78
2025 Q3	$281K	Hold	11,028	–	–	0.14%	75
2025 Q2	$267K	Hold	11,028	–	–	0.14%	67
2025 Q1	$279K	Sell	11,028 -1,367	-11%	-$35.8K	0.16%	62
2024 Q4	$329K	Buy	12,395 +66	+0.5%	+$1.79K	0.2%	60
2024 Q3	$357K	Hold	12,329	–	–	0.22%	57
2024 Q2	$345K	Hold	12,329	–	–	0.23%	55
2024 Q1	$342K	Sell	12,329 -984	-7%	-$27.3K	0.23%	56
2023 Q4	$383K	Sell	13,313 -348	-3%	-$10.5K	0.27%	50
2023 Q3	$453K	Hold	13,661	–	–	0.34%	45
2023 Q2	$501K	Hold	13,661	–	–	0.35%	45
2023 Q1	$557K	Buy	13,661 +3	+0%	+$130	0.4%	41
2022 Q4	$700K	Buy	13,658 +264	+2%	+$12.7K	0.53%	34
2022 Q3	$586K	Hold	13,394	–	–	0.66%	28
2022 Q2	$702K	Hold	13,394	–	–	0.75%	23
2022 Q1	$693K	Hold	13,394	–	–	0.65%	25
2021 Q4	$790K	Hold	13,394	–	–	0.67%	24
2021 Q3	$576K	Sell	13,394 -300	-2%	-$13.3K	0.53%	29
2021 Q2	$536K	Buy	13,694 +300	+2%	+$11.7K	0.49%	30
2021 Q1	$485K	Sell	13,394 -364	-3%	-$12.9K	0.48%	32
2020 Q4	$506K	Buy	+13,758	New	+$505K	0.41%	38

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

ADE LLC's PFE Position: Q1 2026 in Review

ADE LLC held its Pfizer (PFE) position steady in Q1 2026 at 11,028 shares worth $310K. The position accounts for 0.15% of the portfolio, ranked #72.

ADE LLC first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $790K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

ADE LLC held 11,028 shares of Pfizer worth $310K as of Q1 2026.
ADE LLC left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.15% of ADE LLC's portfolio in Q1 2026, its #72 holding.
ADE LLC first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
ADE LLC's Pfizer position peaked at $790K in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on ADE LLC's 13F filing for Q1 2026, filed 14 May 2026.